Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Plasmid DNA Therapeutic Vaccine(GX-188E)

NCT02596243 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

134

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Intraepithelial Neoplasia

Interventions

BIOLOGICAL: GX-188E
BIOLOGICAL: Placebo

Sponsor

Genexine, Inc.